<DOC>
	<DOCNO>NCT01612585</DOCNO>
	<brief_summary>This study advocate Institute Basic Research Clinical Medicine , China Academy Chinese Medical Sciences October 2011 . It fund China major scientific technological specialize project 'significant new formulation new drug ' . Dengzhanxixin kind Chinese Medicine injection use treat Ischemic Stroke coronary heart disease many Chinese hospital . The purpose study determine adverse drug event adverse drug reaction large sample size 30,000 patient .</brief_summary>
	<brief_title>Safety Study Dengzhanxixin ( Chinese Medicine Injection ) Used Hospitals China</brief_title>
	<detailed_description>It common Chinese Medicine Injection use hospital mainland China . However safety problem rise recent year . There could many uncertain factor influence Chinese Medicine Injection clinical practice . Safety surveillance Chinese Medicine injection important problem need sort large sample observational study . A registry study Kudiezi injection safety surveillance 30000 patient conduct April.2012 December.2014 . Eligibility criterion Patients use Dengzhanxixin injection select hospital Data collect three aspect three different form follow : Form A ( green ) : demographic information ；Form B ( pink ) : adverse drug events/reaction； Form C ( white ) : extract information hospital information system laboratory information system Form</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Patients use Dengzhanxixin injection 2012 2014</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>